Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hermansen JU"'
Autor:
Hermansen JU; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yin Y; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Rein ID; Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. sigrid.skanland@ous-research.no.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. sigrid.skanland@ous-research.no.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 May 20; Vol. 8 (1), pp. 107. Date of Electronic Publication: 2024 May 20.
Autor:
Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hermansen JU; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Giliberto M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yin Y; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Hanes R; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Gordon S; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Kuusanmäki H; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Brodersen AM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Andersen AN; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Enserink JM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. sigrid.skanland@ous-research.no.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. sigrid.skanland@ous-research.no.
Publikováno v:
Cell death discovery [Cell Death Discov] 2023 Dec 01; Vol. 9 (1), pp. 435. Date of Electronic Publication: 2023 Dec 01.
Autor:
Almaas R; Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Paediatrics, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; European Reference Network - Rare Liver. Electronic address: runar.almaas@ous-hf.no., Atneosen-Åsegg M; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ytre-Arne ME; Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Melheim M; Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; European Reference Network - Rare Liver., Sorte HS; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Cízková D; Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Reims HM; European Reference Network - Rare Liver; Department of Pathology, Oslo University Hospital, Oslo, Norway., Bezrouk A; Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Harrison SP; Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; European Reference Network - Rare Liver., Strand J; Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Hermansen JU; Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway., Andersen SS; Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway., Eiklid KL; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Mokrý J; Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Sullivan GJ; Department of Pediatric Research, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Pb 4950, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; European Reference Network - Rare Liver., Stray-Pedersen A; European Reference Network - Rare Liver; Norwegian National Unit for Newborn Screening, Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Journal of hepatology [J Hepatol] 2023 Oct; Vol. 79 (4), pp. 945-954. Date of Electronic Publication: 2023 Jun 14.
Autor:
Hermansen JU; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Yin Y; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Urban A; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Myklebust CV; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Karlsen L; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Melvold K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Tveita AA; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Munthe LA; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Tjønnfjord GE; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. sigrid.skanland@ous-research.no.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. sigrid.skanland@ous-research.no.
Publikováno v:
Cell death discovery [Cell Death Discov] 2023 Apr 13; Vol. 9 (1), pp. 125. Date of Electronic Publication: 2023 Apr 13.
Autor:
Hermansen JU; Department of Oncology, Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.; Department of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Wojcik DM; Department of Pediatrics, Haukeland University Hospital, Bergen, Norway., Robinson N; Department of Oncology, Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Pahnke J; Department of Pathology, Section for Neuropathology, Oslo University Hospital, Oslo, Norway.; Department of Pathology, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Pharmacology, Medical Faculty, University of Latvia, Riga, Latvia., Haugland HK; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Jamtøy AH; Department of Pathology, St. Olavs Hospital, Trondheim, Norway., Flaegstad T; Department of Pediatrics, University Hospital of North-Norway, Tromsø, Norway.; Faculty of Health Science, The Arctic University of Norway, Tromsø, Norway., Halvorsen H; Department of Pathology, University Hospital of North-Norway, Tromsø, Norway., Lund B; Department of Pediatrics, St. Olavs Hospital, Trondheim, Norway.; Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Baumbusch LO; Department of Pediatric Research, Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway., Munthe-Kaas MC; Department of Oncology, Division of Pediatric and Adolescent Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Publikováno v:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Aug; Vol. 5 (8), pp. e1555. Date of Electronic Publication: 2021 Sep 20.
Autor:
Skjerven HO; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: h.o.skjerven@medisin.uio.no., Rehbinder EM; Department of Dermatology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Vettukattil R; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., LeBlanc M; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Granum B; Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Haugen G; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hedlin G; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Landrø L; Department of Dermatology, Oslo University Hospital, Oslo, Norway., Marsland BJ; Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia; Department of Biology and Medicine, Centre Hospitalier Universitaire Vaudois-Universitu of Lausanne, Lausanne, Switzerland., Rudi K; Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway., Sjøborg KD; Department of Gynecology and Obstetrics, Østfold Hospital Trust, Kalnes, Norway., Söderhäll C; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Staff AC; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Carlsen KH; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Asarnoj A; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Bains KES; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Carlsen OCL; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Endre KMA; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Granlund PA; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hermansen JU; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Gudmundsdóttir HK; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hilde K; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Håland G; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kreyberg I; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Olsen IC; Research Support Services, Clinical Trials Unit, Oslo University Hospital, Oslo, Norway., Mägi CO; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Nordhagen LS; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; VID Specialized University, Oslo, Norway., Saunders CM; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Skrindo I; Department of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway., Tedner SG; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Værnesbranden MR; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Gynecology and Obstetrics, Østfold Hospital Trust, Kalnes, Norway., Wiik J; Department of Gynecology and Obstetrics, Østfold Hospital Trust, Kalnes, Norway; Department of Obstetrics and Gynecology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden., Jonassen CM; Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway; Center for Laboratory Medicine, Østfold Hospital Trust, Kalnes, Norway., Nordlund B; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Carlsen KCL; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Lancet (London, England) [Lancet] 2020 Mar 21; Vol. 395 (10228), pp. 951-961. Date of Electronic Publication: 2020 Feb 19.
Autor:
Skånland SS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. sigrid.skanland@medisin.uio.no.; K. G. Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. sigrid.skanland@medisin.uio.no.; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. sigrid.skanland@medisin.uio.no.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway. sigrid.skanland@medisin.uio.no., Cremaschi A; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway.; Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Oslo, Norway., Bendiksen H; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hermansen JU; K. G. Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway., Thimiri Govinda Raj DB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway., Munthe LA; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Tjønnfjord GE; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Haematology, Oslo University Hospital, Oslo, Norway., Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Oslo, Norway.
Publikováno v:
Leukemia [Leukemia] 2020 Feb; Vol. 34 (2), pp. 478-487. Date of Electronic Publication: 2019 Aug 30.
Autor:
Hermansen JU; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, University of Oslo, Oslo, Norway., Munthe LA; K. G. Jebsen Centre for B Cell Malignancies, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Taskén K; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, University of Oslo, Oslo, Norway.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Skånland SS; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway. sigrid.skanland@medisin.uio.no.; K. G. Jebsen Centre for B Cell Malignancies, University of Oslo, Oslo, Norway. sigrid.skanland@medisin.uio.no.; K. G. Jebsen Centre for Cancer Immunotherapy, University of Oslo, Oslo, Norway. sigrid.skanland@medisin.uio.no.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. sigrid.skanland@medisin.uio.no.
Publikováno v:
Scientific reports [Sci Rep] 2018 Dec 05; Vol. 8 (1), pp. 17651. Date of Electronic Publication: 2018 Dec 05.
Autor:
Myhrvold IK; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for Inflammation Research, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, University of Oslo, Oslo, Norway., Cremaschi A; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Oslo, Norway., Hermansen JU; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for Inflammation Research, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, University of Oslo, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Munthe LA; Centre for Immune Regulation, Department of Immunology, University of Oslo, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Taskén K; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for Inflammation Research, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway., Skånland SS; Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for Inflammation Research, University of Oslo, Oslo, Norway.; K. G. Jebsen Centre for Cancer Immunotherapy, University of Oslo, Oslo, Norway.
Publikováno v:
Oncotarget [Oncotarget] 2018 Jan 04; Vol. 9 (10), pp. 9273-9284. Date of Electronic Publication: 2018 Jan 04 (Print Publication: 2018).